Pacific Compounding Cefuroxime 10mg/mL Injectable Recall: Particulate Matter Hazard
Pacific Compounding Pharmacy recalls Cefuro: Particulate matter in one lot may cause serious reactions. Stop using affected lot numbers immediately.
Stop using this now
Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after use of product.. FDA analysis identified the particulate as coring of the rubber stopper
Contact the company
What happened, in plain English
Pacific Compounding Pharmacy recalled a specific lot of Cefuroxime 10mg/mL injectable due to particulate matter in the rubber stopper. This could cause serious reactions if injected. The recall affects only one lot number. Read more at govinfonow.com/recall/39691-pacific-compounding-cefuroxime-10mg-ml-injectable-recall-particulate-matter-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/39691-pacific-compounding-cefuroxime-10mg-ml-injectable-recall-particulate-matter-hazard · Updated October 6, 2026 · FDA enforcement record: FDA #D-1076-2019
Cite this page
“Pacific Compounding Cefuroxime 10mg/mL Injectable Recall: Particulate Matter Hazard.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39691-pacific-compounding-cefuroxime-10mg-ml-injectable-recall-particulate-matter-hazard. Based on FDA recall #D-1076-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1076-2019%22&limit=1).
Why it’s dangerous
The particulate matter in the rubber stopper can enter the bloodstream during injection, potentially causing serious reactions like allergic responses or tissue damage. FDA analysis confirmed the particulate was from rubber stopper coring.
Who’s affected
Prescription patients who received the recalled lot number (07232018@15) from Pacific Compounding Pharmacy in Stockton, CA. Patients who have the specific lot number are at risk of serious reactions.
How to tell if you have this one
Check the lot number on the vial: 07232018@15. This product was sold in Stockton, CA by Pacific Compounding Pharmacy and was frozen until September 6, 2018.
- Brand
Pacific Compounding- Category
Drug
What to do — step by step
Stop Using Immediately
Discard the recalled vial with lot number 07232018@15 as it contains particulate matter that could cause serious reactions.
Where it went and when
Where it was distributed
Distributed in California.
FDA distribution: “California” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: California.
Recall timeline
FDA terminated this recall 4.7 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have the recalled product?
Discard the vial with lot number 07232018@15 immediately and contact your healthcare provider for alternative treatment.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1076-2019 (August 23, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1076-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.